The world journal of men's health
Inhibition of PREX1 Reverses Enzalutamide Resistance in Castration-Resistant Prostate Cancer.
Chung Un Lee, Seon-Yong Yeom, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Soo Jeon, Seong Il Seo
Published: 202510.5534/wjmh.250135
Abstract
PURPOSE: Castration-resistant prostate cancer (CRPC) often progresses despite initial responses to enzalutamide owing to the development of resistance. Our study explored the mechanisms underlying resistance in enzalutamide-resistant prostate cancer…
Preview only. Read the full abstract at the source